Key result
STAT-1 or IRF-1 decoy oligodeoxynucleotides reduce endothelial CD40 expression by ~60%.
Answers are grounded in this paper and cite their sources.
Given the significance of CD40-CD40 ligand interactions in chronic inflammatory diseases including atherosclerosis, the transcriptional regulation of CD40 expression as a potential therapeutic target was investigated in human umbilical vein cultured endothelial cells. Exposure to interferon-gamma (IFN-gamma) plus tumor necrosis factor-alpha resulted in a marked synergistic de novo expression of CD40, which, according to electrophoretic mobility shift analysis, was attributable to activation of the transcription factors nuclear factor-kappaB (NF-kappaB), signal transducer and activator of transcription-1 (STAT-1), and interferon regulatory factor-1 (IRF-1). Subsequent time-course studies revealed that de novo synthesis of IRF-1 preceded that of CD40. Decoy oligodeoxynucleotide (ODN) neutralization of STAT-1 or IRF-1, but not of NF-kappaB, inhibited cytokine-stimulated CD40 expression by 60% at both the mRNA and protein levels, and this effect was mimicked by antisense ODN blockade of IRF-1 synthesis. In contrast, CD40 expression in response to IFN-gamma stimulation was sensitive to neutralization of STAT-1 only. These findings suggest that depending on the cytokine composition, CD40 expression in human endothelial cells under proinflammatory conditions is governed by STAT-1 either directly or indirectly through de novo synthesis of IRF-1. Moreover, decoy ODN neutralization of these transcription factors may provide a novel therapeutic option for interfering with CD40-CD40 ligand-mediated inflammatory responses in vivo.
No takes yet. Share an insight, caveat, or question.
Wagner et al. (2002) studied Atherosclerosis and chronic inflammatory diseases. Decoy oligodeoxynucleotide (ODN) neutralization of STAT-1 or IRF-1 vs. Decoy ODN neutralization of NF-kappaB was evaluated on Inhibition of cytokine-stimulated CD40 expression at mRNA and protein levels. Decoy oligodeoxynucleotide neutralization of STAT-1 or IRF-1 inhibited cytokine-stimulated CD40 expression in human endothelial cells by 60% at both mRNA and protein levels.
Synapse has enriched 10 related papers. Consider them for comparative context: